Coinbase Logo

About AB4AD (Antibodies for Alzheimer's Disease)

Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).

Earn up to $2,000 when you buy $50 in crypto

Sign me up
Restrictions apply. See full terms.

11/17/2025, 8:07:58 AM

Trading Insights

Traders

1

Market Stats

Market Cap

$100.72K

FDV

$100.72K

Circ. Supply

1M AB4AD

Max Supply

1M AB4AD

Total Supply

1M AB4AD

Diluted Valuation

$100.50K

Performance

Popularity

Not enough data

Dominance

0%

Volume (24H)

$497.67

-100%

Volume (7D)

Not enough data

Volume (30D)

Not enough data

All time high

$0.10

Price Change (1Y)

-85.16%

Additional details

Market details

AB4AD vs markets

↘ 86.32%

AB4AD vs BTC

↘ 85.96%

AB4AD vs ETH

↘ 85.1%

Tags

0

Network & Addresses

Network
Address

Base

0x57414656AC535680367f519eeC9f0D7Ffe99e2D0

Price history

Time
Price
Change
Today
$0.10
0.00%
1 Day
$0.10
0.00%
1 Week
$0.10
↘ 3.08%
1 Month
$0.0667
↗ 50.76%
1 Year
$0.00
↘ 85.16%

FAQ

Earn up to $2,000 when you buy $50 in crypto

Earn free crypto after making your first purchase.

Guides

AB4AD (Antibodies for Alzheimer's Disease) calculator

Related assets

Legal